$2.64
-0.02-0.75%
Last update: Oct 26, 4:00 PM
BridgeBio Oncology Therapeutics Inc (BBOT) Stock Price, Quote, News & History
BBOTNASDAQ
U.S. stocks fell, Nasdaq down 100 points. Penguin Solutions Inc (PENG) rose 18.8% after better-than-expected earnings. Other big gainers: PRME, BZH, WULF, VRXA,...
You can purchase shares of BridgeBio Oncology (NASDAQ:BBOT) through any online brokerage.
Other companies in BridgeBio Oncology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
BridgeBio Oncology has a consensus price target of $21.20.
The stock price for BridgeBio Oncology (NASDAQ: BBOT) is $2.64 last updated October 26, 2026 at 4:00 PM EDT.
There are no upcoming dividends for BridgeBio Oncology.
BridgeBio Oncology does not have any upcoming earnings scheduled.
There is no upcoming split for BridgeBio Oncology.
BridgeBio Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and...
